2021 Fiscal Year Final Research Report
Structure–activity study and analysis of mechanism of action of vibsanins focused on pro-/anti-inflammatory switching
Project/Area Number |
19K05846
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 38040:Bioorganic chemistry-related
|
Research Institution | Kagawa University |
Principal Investigator |
Yanagita Ryo 香川大学, 農学部, 准教授 (10598121)
|
Co-Investigator(Kenkyū-buntansha) |
川浪 康弘 香川大学, 農学部, 教授 (30169742)
|
Project Period (FY) |
2019-04-01 – 2022-03-31
|
Keywords | プロテインキナーゼC / 構造活性相関 / 分子動力学シミュレーション |
Outline of Final Research Achievements |
Vibsanin A, a protein kinase C (PKC) activator isolated from Viburnum odoratissimum tree, was found to have about 4000-fold binding selectivity between PKCα-C1A and δ-C1B domains, which is the highest among known PKC ligands. Molecular dynamics simulation presented the binding mode of vibsanin A with the PKCδ-C1B domain, wherein CH-O interactions are involved. LC-MS analysis suggested that the chemical instability of vibsanin A is attributable to its susceptibility to oxidation. Furthermore, we found that (8Z)-5,10-di-epi-vibsanin C (vibsanin D), not vibsanin C, has the potential as a lead scaffold for developing novel PKC ligands.
|
Free Research Field |
天然物化学
|
Academic Significance and Societal Importance of the Research Achievements |
Vibsanin AのPKC結合活性と化学的安定性についての基礎的な知見は、今後vibsaninの作用機序解析や誘導体開発を行ううえでの基盤となる。PKC活性化剤はがん、アルツハイマー病、HIV感染などの治療薬候補として研究が行われており、vibsanin類やその誘導体・アナログはこういった疾患に対する治療薬開発のリードとして有望である。
|